NHS England Bowel Cancer Screening Programme Managed Service
NHS England · awarded 31 January 2026 · delivered in England
Who
| Buyer | NHS England Leeds |
|---|---|
| Supplier |
GXO LOGISTICS UK LIMITED |
| Category | services |
| Classification | Laboratory, optical and precision equipments (excl. glasses) CPV 38000000 |
| Notice published | 12 February 2026 |
What it is for
The appointment of GXO Logistics Ltd to deliver the Managed Service Provider contract for the continued provision of Faecal Immunochemical Test (FIT) home testing kits to those eligible for the bowel cancer screening programme throughout England. These tests allow those at risk of cancer, and requiring further tests, to be identified and provision is an essential component of the screening pathway. Further tests after FIT are typically screening specialist practitioner review and a screening colonoscopy. The MSP contract broadly covers; the sending of personalised FIT kits to eligible participants in England, management of the logistics to return kits to the five NHS bowel cancer screening hubs, the supply of analysers and consumables to all hubs to test the kits, provision of training for hub staff to analyse the kits, the systems to allow results to be transferred to the Bowel Cancer Screening System (BCSS) software and a helpdesk function to resolve any issues with the service provision.
Read the original award notice on Contracts Finder →
Other contracts from this buyer
1269 awards on file, worth £50.2bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 4 Mar 2026 | New Hospital Programme - Hospital 2.0 Alliance (H2A) FrameworkEngland | NHS England | Willmott Dixon Construction Limited +9 | £37.0bn |
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 19 Dec 2024 | NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinScotland | NHS England | CSL Behring UK Ltd +5 | £905.2m |
| 31 May 2024 | NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands | NHS England | Pfizer Ltd +8 | £765.0m |
Everything NHS England has awarded →
Other contracts won by this supplier
3 awards on file, worth £429.4m.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 31 Jan 2026 | NHS England Bowel Cancer Screening Programme Managed ServiceEngland | NHS England | GXO LOGISTICS UK LIMITED | £210.5m |
| 31 Jan 2026 | NHS England Bowel Cancer Screening Programme Managed ServiceEngland | NHS England | GXO LOGISTICS UK LIMITED | £210.5m |
| 10 Oct 2024 | ORT0164 -GXO Logistics -Distribution and warehousing Contract | National Highways | GXO Logistics UK Limited | £8.5m |